Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts.
Kupiec-Weglinski
J W
JW
Harvard Medical School, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Sablinski
T
T
Hancock
W W
WW
Mix
C T
CT
Tilney
N L
NL
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003433:Crosses, Genetic; D003524:Cyclosporins / Q000627:therapeutic use*; D004357:Drug Synergism; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D015375:Receptors, Interleukin-2